ChemoMetec AS (STU:CHY) Total Payout Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:CHY ChemoMetec AS STU:CHY
94 GF Score
Price €70.25
GF Value €68.87
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is ChemoMetec AS Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

ChemoMetec AS's current Total Payout Ratio is .

ChemoMetec AS Total Payout Ratio Related Terms

ChemoMetec AS Total Payout Ratio Historical Data

* Premium members only.

The historical data trend for ChemoMetec AS's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ChemoMetec AS Total Payout Ratio Chart

ChemoMetec AS Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ChemoMetec AS Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

STU:CHY vs ABT, SYK, MDT: Total Payout Ratio Comparison

For the Medical Devices subindustry, ChemoMetec AS's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ChemoMetec AS Total Payout Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where ChemoMetec AS's Total Payout Ratio falls into.


STU:CHY
94GF Score
ChemoMetec AS STU:CHY
Total Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ChemoMetec AS Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

ChemoMetec AS's Total Payout Ratio for the fiscal year that ended in Jun. 2026 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-5.1619072997274 + 0 + -16.507686894223) / 27.023362601748
=0.80

ChemoMetec AS's Total Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-5.1597401790971 + 0 + -0.1844489885987) / 14.435200898936
=0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is ChemoMetec AS (STU:CHY) Overvalued in 2026?

Based on GuruFocus' analysis, ChemoMetec AS stock appears to be overvalued. The current stock price of €70.25 is trading 2% above its estimated GF Value™ of €68.87. GuruFocus considers ChemoMetec AS to be Fairly Valued.

Key valuation signals for STU:CHY:

  • Total Payout Ratio:
  • GF Value™: €68.87 vs. price of €70.25 (2% above fair value)
  • GF Score™: 94/100 with 3 warning signs

No single metric tells the full story. See the STU:CHY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ChemoMetec AS Business Description

Address Gydevang 43, Allerod, DNK, 3450
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
94GF Score

Get the complete analysis for STU:CHY

Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€70.25
Price
€68.87
GF Value